Large Vessel Lesions Linked with Poor Treatment Outcomes in Giant Cell Arteritis
The presence of large vessel lesions detected by imaging at baseline was significantly linked with poor treatment outcomes in patients with giant cell arteritis, according to a study published online in Arthritis Research & Therapy.
“Interestingly, among large vessel lesions, any aortic lesions are more likely to be associated with the event of poor treatment outcomes. These data suggest that giant cell arteritis patients with large vessel lesions, especially aortic lesions, may be resistant to initial conventional immunosuppressive therapy without biologics,” researchers wrote.
_______________________________________________________________________
You may also like...
Quiz: Giant Cell Arteritis
Rheumatic Regional Pain Syndromes Affect Many Close Relatives of Patients With RA
TNF Inhibitors May Increase Inflammatory Central Nervous System Events Risk
_______________________________________________________________________
The retrospective study included 139 patients in Japan who were newly diagnosed with giant cell arteritis and treated with glucocorticoids between 2007 and 2014. Among them, 77.7% had cranial lesions, 41.7% had polymyalgia rheumatica, and 52.5% had large vessel lesions.
Among 119 participants observed for 24 weeks or longer, the average initial dose of prednisolone was 0.76 mg/kg/day, and 29.4% received any concomitant immunosuppressive drugs at baseline. According to the study, 41 patients (34.5%) had poor treatment outcomes: 13 patients did not achieve clinical remission by week 24, and 28 had a relapse within the year after achieving clinical remission.
Poor treatment outcomes occurred in 47.5% of participants with large vessel lesions and in 17.7% of participants without large vessel lesions, researchers found. While a multivariable model showed large vessel lesions at baseline to be significantly linked with poor treatment outcomes, neither cranial lesions nor and polymyalgia rheumatica appeared to increase the risk of poor treatment outcomes.
“The initial treatment intensity in the treatment algorithm of giant cell arteritis could be determined based upon the presence or absence of large vessel lesions detected by imaging at baseline,” researchers concluded.
—Jolynn Tumolo
Reference
Sugihara T, Hasegawa H, Uchida HA, et al. Associated factors of poor treatment outcomes in patients with giant cell arteritis: clinical implication of large vessel lesions. Arthritis Res Ther. 2020;22(1):72. doi:10.1186/s13075-020-02171-6


